Toronto Dominion Bank Alnylam Pharmaceuticals, Inc. Transaction History

Toronto Dominion Bank

$61.6 Billion
Q2 2024

A detailed history of Toronto Dominion Bank transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Toronto Dominion Bank holds 12,151 shares of ALNY stock, worth $3.34 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,151

Previous 12,986 6.43%

Holding current value

$3.34 Million

Previous $1.94 Million 52.16%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$143.31 - $247.0 $119,663 - $206,245	-835 Reduced 6.43%	12,151 $2.95 Million
Q1 2024 May 14, 2024	SELL	$146.51 - $198.2 $5.3 Million - $7.17 Million	-36,161 Reduced 73.58%	12,986 $1.94 Million
Q4 2023 Feb 13, 2024	SELL	$151.41 - $196.57 $925,872 - $1.2 Million	-6,115 Reduced 11.07%	49,147 $9.41 Million
Q3 2023 Feb 14, 2024	BUY	$170.77 - $211.65 $4.17 Million - $5.16 Million	24,400 Added 79.06%	55,262 $9.79 Million
Q3 2023 Nov 14, 2023	BUY	$170.77 - $211.65 $4.17 Million - $5.16 Million	24,400 Added 79.06%	55,262 $9.79 Million
Q2 2023 Feb 14, 2024	SELL	$185.01 - $212.05 $3.38 Million - $3.88 Million	-18,285 Reduced 37.2%	30,862 $5.86 Million
Q2 2023 Aug 10, 2023	SELL	$185.01 - $212.05 $613,678 - $703,369	-3,317 Reduced 9.7%	30,862 $5.86 Million
Q1 2023 May 11, 2023	SELL	$182.66 - $235.53 $455,006 - $586,705	-2,491 Reduced 6.79%	34,179 $6.84 Million
Q4 2022 Feb 07, 2023	BUY	$185.53 - $241.31 $1.84 Million - $2.39 Million	9,911 Added 37.04%	36,670 $8.71 Million
Q3 2022 Nov 09, 2022	SELL	$138.54 - $232.0 $8,450 - $14,152	-61 Reduced 0.23%	26,759 $5.35 Million
Q2 2022 Aug 11, 2022	BUY	$120.42 - $169.29 $145,346 - $204,333	1,207 Added 4.71%	26,820 $3.91 Million
Q1 2022 May 09, 2022	BUY	$127.18 - $173.91 $277,888 - $379,993	2,185 Added 9.33%	25,613 $4.18 Million
Q4 2021 Feb 04, 2022	BUY	$159.56 - $209.29 $1.29 Million - $1.69 Million	8,089 Added 52.73%	23,428 $3.97 Million
Q3 2021 Nov 08, 2021	SELL	$169.75 - $207.73 $76,557 - $93,686	-451 Reduced 2.86%	15,339 $2.9 Million
Q2 2021 Aug 13, 2021	BUY	$128.63 - $176.89 $2.03 Million - $2.79 Million	15,790 New	15,790 $2.68 Million

Others Institutions Holding ALNY

# of Institutions

614

Shares Held

108M

Call Options Held

2.33M

Put Options Held

2.17M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $33.8B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Toronto Dominion Bank, based on Form 13F filings with the SEC.

News

Stay updated on Toronto Dominion Bank with notifications on news.

Account

Toronto Dominion Bank Alnylam Pharmaceuticals, Inc. Transaction History